People with metastatic breast cancer often receive a series of treatments, but for those with tumors that carry a mutation in the Her2 gene, a new treatment called Enhertu® shows promise. I’Quasia Russell, a woman with breast cancer who was treated by Sylvia Adams, MD, professor in the Department of Medicine and director of the Breast Cancer Center at NYU Langone Health’s Perlmutter Cancer Center, tells her story to ABC7NY.

“We found a Her2 mutation in her tumor, an abnormality. And that’s when she started to benefit from all these enormous new advances in the treatment for metastatic Her2-positive breast cancer,” Dr. Adams says. “She’s been doing fantastic. Her scans show that the tumor is shrinking very nicely from fist-sized tumors, now half in size.”

Watch more on ABC7NY.